Drug
abobotulinumtoxinA clinical trials
- studies test it
- 8
- open now
- 2
- in phase 3
- 2
- first study started
- 2014
Keep track of what changes. Save the abobotulinumtoxinA studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
8 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2014 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 2
- Phase 4
- 5
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 5
Galderma R&D (2) · Espad Pharmed (1) · Vanderbilt University Medical Center (1) · David M. Simpson (1) · Neurology Center of New England P.C. (1) · St Joseph University, Beirut, Lebanon (1) · Detroit Clinical Research Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses abobotulinumtoxinA is read from its arms, and is right about nine times in ten.
Testing it · 8
- Impact of Dysport on PMFF Donor ScarNot yet recruitingPhase 4Vanderbilt University Medical CenterNCT07720726Written as Abobotulinumtoxin-A
- A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb TremorRecruitingPhase 4David M. SimpsonNCT03136341Written as Abobotulinum toxin A
- A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar LinesCompletedPhase 3Espad PharmedNCT06946160Written as Abobotulinumtoxin A (Espad Pharmed Darou Co.)
- Safety and Efficacy of Treatment With Azzalure, Restylane/Emervel Filler and Restylane SkinboosterCompletedPhase 4Galderma R&DNCT02297503Written as Azzalure
- A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar LinesCompletedPhase 4Galderma R&DNCT02108158Written as Azzalure
- " Treating MS Patients With Lower Extremity Spasticity Using Dysport"Status unknownPhase 3Neurology Center of New England P.C.NCT03585569Written as Abobotulinumtoxin A
- Frontalis Botulinum ToxinStatus unknownPhase 4St Joseph University, Beirut, LebanonNCT03186001Written as Abobotulinum toxin A
- Pilot Study for Use of Dysport in Treatment of Vocal Tics in Patients With Tourette's SyndromeStatus unknownNot applicableDetroit Clinical Research CenterNCT02187679Written as Abobotulinum toxin A
Given in every arm · 1 — abobotulinumtoxinA is usual care beside what is tested
Codes
What other systems call abobotulinumtoxinA · ClinicalTrials.gg INT005478
- MeSH (NLM) C542869abobotulinumtoxinAOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C542869 | abobotulinumtoxinA | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.